Update on nephrogenic systemic fibrosis: are we making progress?

Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C

(2010) Thomas Frenzel et al.   INVESTIGATIVE RADIOLOGY

Nephrogenic Systemic Fibrosis and Management of High-risk Patients

(2009) Ersan Altun et al.   ACADEMIC RADIOLOGY

Effects of gadolinium contrast agents in naïve and nephrectomized rats: Relevance to nephrogenic systemic fibrosis

(2009) D. Grant et al.   ACTA RADIOLOGICA

Analysis of the Contrast Agent Magnevist and Its Transmetalation Products in Blood Plasma by Capillary Electrophoresis/Electrospray Ionization Time-of-Flight Mass Spectrometry

(2009) Jens Künnemeyer et al.   ANALYTICAL CHEMISTRY

Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents

(2009) Peter J. Wermuth et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of lanthanoids as X-ray contrast agents

(2009) Hubertus Pietsch et al.   EUROPEAN JOURNAL OF RADIOLOGY

The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis – A mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide

(2009) T. Steger-Hartmann et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Effects of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents on Human Skin in Organ Culture and Human Skin Fibroblasts

(2009) James Varani et al.   INVESTIGATIVE RADIOLOGY

Impact of Renal Impairment on Long-Term Retention of Gadolinium in the Rodent Skin Following the Administration of Gadolinium-Based Contrast Agents

(2009) Hubertus Pietsch et al.   INVESTIGATIVE RADIOLOGY

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An Update

(2009) Jean-Marc Idée et al.   RADIOLOGIC CLINICS OF NORTH AMERICA

Nephrogenic Systemic Fibrosis in Rats Treated with Erythropoietin and Intravenous Iron

(2009) Thomas A. Hope et al.   RADIOLOGY

Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy—Report from Two U.S. Universities

(2009) Ersan Altun et al.   RADIOLOGY

Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases

(2009) Javier Perez-Rodriguez et al.   RADIOLOGY

Nephrogenic systemic fibrosis: experimental studies confound prevailing theory of free gadolinium as a causative factor

(2008) Jarl Jakobsen   ACTA RADIOLOGICA

Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting

(2008) Dale R. Broome   EUROPEAN JOURNAL OF RADIOLOGY

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

(2008) Martin A. Sieber et al.   EUROPEAN RADIOLOGY

Validity of the Animal Models for Nephrogenic Systemic Fibrosis

(2008) Sameh K. Morcos   INVESTIGATIVE RADIOLOGY

Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligand

(2008) Martin A. Sieber et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Quantification of gadolinium in nephrogenic systemic fibrosis: Re-examination of a reported cohort with analysis of clinical factors

(2008) Anand Khurana et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers

(2008) Martin R. Prince et al.   RADIOLOGY

NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis Risk: Is There a Difference between Gadolinium-Based Contrast Agents?

(2008) Jeffrey G. Penfield et al.   SEMINARS IN DIALYSIS

A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast Media

(2007) Martin A. Sieber et al.   INVESTIGATIVE RADIOLOGY